RAFAEL
RUBIO GARCÍA
Profesor titular de universidad
![Foto de RAFAEL](/img/uploaded/6CA654DD031F6FEF08160B3A8AA5CC20.jpg)
![Foto de Medical Research Council](/img/noimage_org.png)
Medical Research Council
Londres, Reino UnidoPublicacions en col·laboració amb investigadors/es de Medical Research Council (5)
2016
-
Efavirenz versus boosted atazanavir-containing regimens and immunologic, virologic, and clinical outcomes: A prospective study of HIV-positive individuals
Medicine (United States), Vol. 95, Núm. 41
2014
-
Opportunistic infections and AIDS malignancies early after initiating combination antiretroviral therapy in high-income countries
AIDS, Vol. 28, Núm. 16, pp. 2461-2473
2008
-
Inferior clinical outcome of the CD4+ cell count-guided antiretroviral treatment interruption strategy in the SMART study: Role of CD4+ cell counts and HIV RNA levels during follow-up
Journal of Infectious Diseases, Vol. 197, Núm. 8, pp. 1145-1155
-
Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART Study
Journal of Infectious Diseases, Vol. 197, Núm. 8, pp. 1133-1144
-
Risk for opportunistic disease and death after reinitiating continuous antiretroviral therapy in patients with HIV previously receiving episodic therapy: A randomized trial
Annals of Internal Medicine, Vol. 149, Núm. 5, pp. 289-299